Cite
APA Citation
shi, y., Rogers, R., Vieira, K., Merhi, B., Osband, A., Bayliss, G., Gohh, R., Morrissey, P., & Farmakiotis, D. (n.d.). 576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients. Open forum infectious diseases, 7, S352–S353. http://access.bl.uk/ark:/81055/vdc_100121927421.0x000005